Showing results (351-360 of 753) with videos related to
Sort By:
Pageof 76
Acta Neurochirurgica|August 17, 2010
MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion statusJonathan H Sherman, Daniel M Prevedello, Lubdha Shah, et al.Cell Cycle (Georgetown, Tex.)|October 5, 2013
microRNA-34a promotes DNA damage and mitotic catastropheAlexander V Kofman, Jungeun Kim, So Yeon Park, et al.Mutation Research|July 29, 2018
Improved molecular karyotyping in glioblastomaIan E Burbulis, Margaret B Wierman, Matt Wolpert, et al.Neuro-Oncology|June 8, 2022
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.Neuro-Oncology Advances|May 22, 2023
An expanded role for surgery in grade 3 1p/19q co-deleted oligodendrogliomaSaksham Gupta, Noah L Nawabi, Siva Emani, et al.Neuro-Oncology|November 11, 2022
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primariesNayan Lamba, Daniel N Cagney, Paul J Catalano, et al.Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.Neuro-Oncology|September 6, 2014
Immunotherapy advances for glioblastomaDavid A Reardon, Gordon Freeman, Catherine Wu, et al.Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.Pageof 76